PTP1B and TCPTP - Nonredundant phosphatases in insulin signaling and glucose homeostasis

FEBS Journal

Volumn 280, Issue 2, 2013, Pages 445-458

  Tiganis, Tony ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

insulin receptor; insulin resistance; insulin signaling; protein tyrosine phosphatase; PTP1B glucose homeostasis; TCPTP; type 2 diabetes; tyrosine phosphorylation

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BERBERINE; GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; ISIS 113715; MESSENGER RNA; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR; RESVERATROL;

DEPHOSPHORYLATION; DRUG TARGETING; ENZYME INHIBITION; GENE; GENE DELETION; GENETIC MODEL; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HORMONAL REGULATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PTPN1 GENE; PTPN2 GENE; REVIEW;

ANIMALS; DIABETES MELLITUS, TYPE 2; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

MUS;

EID: 84872770077     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2012.08563.x     Document Type: Review

References (134)

1. Wild S, Roglic G, Green A, Sicree R, &, King H, (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053.
2. Shaw JE, Sicree RA, &, Zimmet PZ, (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87, 4-14.
3. Saltiel AR, &, Kahn CR, (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799-806.
4. Defronzo RA, (2009) Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58, 773-795.
5. Pratipanawatr W, Pratipanawatr T, Cusi K, Berria R, Adams JM, Jenkinson CP, Maezono K, DeFronzo RA, &, Mandarino LJ, (2001) Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation. Diabetes 50, 2572-2578.
6. Krook A, Bjornholm M, Galuska D, Jiang XJ, Fahlman R, Myers MG Jr, Wallberg-Henriksson H, &, Zierath JR, (2000) Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 49, 284-292.
7. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR, &, Mandarino LJ, (2000) Insulin resistance differentially affects the PI3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 105, 311-320.
8. Caro JF, Ittoop O, Pories WJ, Meelheim D, Flickinger EG, Thomas F, Jenquin M, Silverman JF, Khazanie PG, &, Sinha MK, (1986) Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity. J Clin Invest 78, 249-258.
9. Nyomba BL, Ossowski VM, Bogardus C, &, Mott DM, (1990) Insulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans. Am J Physiol 258, E964-974.
10. Caro JF, Sinha MK, Raju SM, Ittoop O, Pories WJ, Flickinger EG, Meelheim D, &, Dohm GL, (1987) Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 79, 1330-1337.
11. Goldstein BJ, Ahmad F, Ding W, Li PM, &, Zhang WR, (1998) Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases. Mol Cell Biochem 182, 91-99.
12. Drake PG, &, Posner BI, (1998) Insulin receptor-associated protein tyrosine phosphatase(s): role in insulin action. Mol Cell Biochem 182, 79-89.
13. Asante-Appiah E, &, Kennedy BP, (2003) Protein tyrosine phosphatases: the quest for negative regulators of insulin action. Am J Physiol Endocrinol Metab 284, E663-670.
14. Cheng A, Dube N, Gu F, &, Tremblay ML, (2002) Coordinated action of protein tyrosine phosphatases in insulin signal transduction. Eur J Biochem 269, 1050-1059.
15. Goldstein BJ, (2002) Protein-tyrosine phosphatases: emerging targets for therapeutic intervention in type 2 diabetes and related states of insulin resistance. J Clin Endocrinol Metab 87, 2474-2480.
16. Johnson TO, Ermolieff J, &, Jirousek MR, (2002) Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat Rev Drug Discov 1, 696-709.
17. Plum L, Belgardt BF, &, Bruning JC, (2006) Central insulin action in energy and glucose homeostasis. J Clin Invest 116, 1761-1766.
18. White MF, (1998) The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem 182, 3-11.
19. Eck MJ, Dhe-Paganon S, Trub T, Nolte RT, &, Shoelson SE, (1996) Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell 85, 695-705.
20. Cheng Z, Tseng Y, &, White MF, (2010) Insulin signaling meets mitochondria in metabolism. Trends Endocrinol Metab 21, 589-598.
21. Ng Y, Ramm G, Lopez JA, &, James DE, (2008) Rapid activation of Akt2 is sufficient to stimulate GLUT4 translocation in 3T3-L1 adipocytes. Cell Metab 7, 348-356.
22. Bai L, Wang Y, Fan J, Chen Y, Ji W, Qu A, Xu P, James DE, &, Xu T, (2007) Dissecting multiple steps of GLUT4 trafficking and identifying the sites of insulin action. Cell Metab 5, 47-57.
23. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB III, Kaestner KH, Bartolomei MS, Shulman GI, &, Birnbaum MJ, (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292, 1728-1731.
24. Abdul-Ghani MA, &, DeFronzo RA, (2010) Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol doi:10.1155/2010/476279.
25. Sabio G, Cavanagh-Kyros J, Ko HJ, Jung DY, Gray S, Jun JY, Barrett T, Mora A, Kim JK, &, Davis RJ, (2009) Prevention of steatosis by hepatic JNK1. Cell Metab 10, 491-498.
26. Sabio G, Kennedy NJ, Cavanagh-Kyros J, Jung DY, Ko HJ, Ong H, Barrett T, Kim JK, &, Davis RJ, (2010) Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance. Mol Cell Biol 30, 106-115.
27. Sabio G, Das M, Mora A, Zhang Z, Jun JY, Ko HJ, Barrett T, Kim JK, &, Davis RJ, (2008) A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322, 1539-1543.
28. Kim JK, Fillmore JJ, Sunshine MJ, Albrecht B, Higashimori T, Kim DW, Liu ZX, Soos TJ, Cline GW, O'Brien WR, et al. (2004) PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest 114, 823-827.
29. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, &, Karin M, (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11, 191-198.
30. Bevan AP, Drake PG, Yale JF, Shaver A, &, Posner BI, (1995) Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis. Mol Cell Biochem 153, 49-58.
31. Tonks NK, Diltz CD, &, Fischer EH, (1988) Purification of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem 263, 6722-6730.
32. Tonks NK, Diltz CD, &, Fischer EH, (1988) Characterization of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem 263, 6731-6737.
33. Frangioni JV, Beahm PH, Shifrin V, Jost CA, &, Neel BG, (1992) The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell 68, 545-560.
34. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, et al. (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283, 1544-1548.
35. Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, et al. (2000) Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20, 5479-5489.
36. Tiganis T, &, Bennett AM, (2007) Protein tyrosine phosphatase function: the substrate perspective. Biochem J 402, 1-15.
37. Haj FG, Zabolotny JM, Kim YB, Kahn BB, &, Neel BG, (2005) Liver specific protein-tyrosine phosphatase 1B (PTP1B). Re-expression alters glucose homeostasis of PTP1B-/-mice. J Biol Chem 280, 15038-15046.
38. Bence KK, Delibegovic M, Xue B, Gorgun CZ, Hotamisligil GS, Neel BG, &, Kahn BB, (2006) Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med 12, 917-924.
39. Delibegovic M, Zimmer D, Kauffman C, Rak K, Hong EG, Cho YR, Kim JK, Kahn BB, Neel BG, &, Bence KK, (2009) Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced ER stress. Diabetes 58, 590-599.
40. Seely BL, Staubs PA, Reichart DR, Berhanu P, Milarski KL, Saltiel AR, Kusari J, &, Olefsky JM, (1996) Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes 45, 1379-1385.
41. Ahmad F, Li PM, Meyerovitch J, &, Goldstein BJ, (1995) Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway. J Biol Chem 270, 20503-20508.
42. Bandyopadhyay D, Kusari A, Kenner KA, Liu F, Chernoff J, Gustafson TA, &, Kusari J, (1997) Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin. J Biol Chem 272, 1639-1645.
43. Dadke S, Kusari J, &, Chernoff J, (2000) Down-regulation of insulin signaling by protein tyrosine phosphatase (PTP) 1B is mediated by an N-terminal binding region. J Biol Chem 275, 23642-23647.
44. Kenner KA, Anyanwu E, Olefsky JM, &, Kusari J, (1996) Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling. J Biol Chem 271, 19810-19816.
45. Walchli S, Curchod ML, Gobert RP, Arkinstall S, &, Hooft van Huijsduijnen R, (2000) Identification of tyrosine phosphatases that dephosphorylate the insulin receptor. A brute force approach based on 'substrate-trapping' mutants. J Biol Chem 275, 9792-9796.
46. Cicirelli MF, Tonks NK, Diltz CD, Weiel JE, Fischer EH, &, Krebs EG, (1990) Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes. Proc Natl Acad Sci USA 87, 5514-5518.
47. Chen H, Wertheimer SJ, Lin CH, Katz SL, Amrein KE, Burn P, &, Quon MJ, (1997) Protein-tyrosine phosphatases PTP1B and syp are modulators of insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. J Biol Chem 272, 8026-8031.
48. Chen H, Cong LN, Li Y, Yao ZJ, Wu L, Zhang ZY, Burke TR Jr, &, Quon MJ, (1999) A phosphotyrosyl mimetic peptide reverses impairment of insulin-stimulated translocation of GLUT4 caused by overexpression of PTP1B in rat adipose cells. Biochemistry 38, 384-389.
49. Egawa K, Maegawa H, Shimizu S, Morino K, Nishio Y, Bryer-Ash M, Cheung AT, Kolls JK, Kikkawa R, &, Kashiwagi A, (2001) Protein tyrosine phosphatase-1B negatively regulates insulin signaling in L6 myocytes and Fao hepatoma cells. J Biol Chem 276, 10207-10211.
50. Venable CL, Frevert EU, Kim YB, Fischer BM, Kamatkar S, Neel BG, &, Kahn BB, (2000) Overexpression of protein-tyrosine phosphatase-1B in adipocytes inhibits insulin-stimulated phosphoinositide 3-kinase activity without altering glucose transport or Akt/protein kinase B activation. J Biol Chem 275, 18318-18326.
51. Xie L, Lee SY, Andersen JN, Waters S, Shen K, Guo XL, Moller NP, Olefsky JM, Lawrence DS, &, Zhang ZY, (2003) Cellular effects of small molecule PTP1B inhibitors on insulin signaling. Biochemistry 42, 12792-12804.
52. Cromlish WA, Tang M, Kyskan R, Tran L, &, Kennedy BP, (2006) PTP1B-dependent insulin receptor phosphorylation/residency in the endocytic recycling compartment of CHO-IR cells. Biochem Pharmacol 72, 1279-1292.
53. Stuible M, Zhao L, Aubry I, Schmidt-Arras D, Bohmer FD, Li CJ, &, Tremblay ML, (2007) Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives. ChemBioChem 8, 179-186.
54. Loh K, Merry TL, Galic S, Wu BJ, Watt MJ, Zhang S, Zhang ZY, Neel BG, &, Tiganis T, (2011) T cell protein tyrosine phosphatase (TCPTP) deficiency in muscle does not alter insulin signalling and glucose homeostasis in mice. Diabetologia 55, 468-478.
55. Bakhtiyari S, Meshkani R, Taghikhani M, Larijani B, &, Adeli K, (2010) Protein tyrosine phosphatase-1B (PTP-1B) knockdown improves palmitate-induced insulin resistance in C2C12 skeletal muscle cells. Lipids 45, 237-244.
56. Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, Kim YB, Elmquist JK, Tartaglia LA, Kahn BB, et al. (2002) PTP1B regulates leptin signal transduction in vivo. Dev Cell 2, 489-495.
57. Cheng A, Uetani N, Simoncic PD, Chaubey VP, Lee-Loy A, McGlade CJ, Kennedy BP, &, Tremblay ML, (2002) Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell 2, 497-503.
58. Ali MI, Ketsawatsomkron P, Belin de Chantemele EJ, Mintz JD, Muta K, Salet C, Black SM, Tremblay ML, Fulton DJ, Marrero MB, et al. (2009) Deletion of protein tyrosine phosphatase 1b improves peripheral insulin resistance and vascular function in obese, leptin-resistant mice via reduced oxidant tone. Circ Res 105, 1013-1022.
59. Basavarajappa DK, Gupta VK, Dighe R, Rajala A, &, Rajala RV, (2011) Phosphorylated Grb14 is an endogenous inhibitor of retinal protein tyrosine phosphatase 1B, and light-dependent activation of Src phosphorylates Grb14. Mol Cell Biol 31, 3975-3987.
60. Cannon B, &, Nedergaard J, (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84, 277-359.
61. Matsuo K, Bettaieb A, Nagata N, Matsuo I, Keilhack H, &, Haj FG, (2011) Regulation of brown fat adipogenesis by protein tyrosine phosphatase 1B. PLoS One 6, e16446.
62. Miranda S, Gonzalez-Rodriguez A, Revuelta-Cervantes J, Rondinone CM, &, Valverde AM, (2010) Beneficial effects of PTP1B deficiency on brown adipocyte differentiation and protection against apoptosis induced by pro- and anti-inflammatory stimuli. Cell Signal 22, 645-659.
63. Entingh AJ, Taniguchi CM, &, Kahn CR, (2003) Bi-directional regulation of brown fat adipogenesis by the insulin receptor. J Biol Chem 278, 33377-33383.
64. Tseng YH, Kriauciunas KM, Kokkotou E, &, Kahn CR, (2004) Differential roles of insulin receptor substrates in brown adipocyte differentiation. Mol Cell Biol 24, 1918-1929.
65. Picardi PK, Calegari VC, Prada Pde O, Moraes JC, Araujo E, Marcondes MC, Ueno M, Carvalheira JB, Velloso LA, &, Saad MJ, (2008) Reduction of hypothalamic protein tyrosine phosphatase improves insulin and leptin resistance in diet-induced obese rats. Endocrinology 149, 3870-3880.
66. Inoue H, Ogawa W, Asakawa A, Okamoto Y, Nishizawa A, Matsumoto M, Teshigawara K, Matsuki Y, Watanabe E, Hiramatsu R, et al. (2006) Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab 3, 267-275.
67. Scherer T, O'Hare J, Diggs-Andrews K, Schweiger M, Cheng B, Lindtner C, Zielinski E, Vempati P, Su K, Dighe S, et al. (2011) Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab 13, 183-194.
68. Haj FG, Verveer PJ, Squire A, Neel BG, &, Bastiaens PI, (2002) Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum. Science 295, 1708-1711.
69. Romsicki Y, Reece M, Gauthier JY, Asante-Appiah E, &, Kennedy BP, (2004) Protein tyrosine phosphatase-1B dephosphorylation of the insulin receptor occurs in a perinuclear endosome compartment in human embryonic kidney 293 cells. J Biol Chem 279, 12868-12875.
70. Kushner JA, Haj FG, Klaman LD, Dow MA, Kahn BB, Neel BG, &, White MF, (2004) Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice. Diabetes 53, 61-66.
71. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, et al. (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900-904.
72. Gonzalez-Rodriguez A, Mas Gutierrez JA, Sanz-Gonzalez S, Ros M, Burks DJ, &, Valverde AM, (2010) Inhibition of PTP1B restores IRS1-mediated hepatic insulin signaling in IRS2-deficient mice. Diabetes 59, 588-599.
73. Xue B, Kim YB, Lee A, Toschi E, Bonner-Weir S, Kahn CR, Neel BG, &, Kahn BB, (2007) Protein-tyrosine phosphatase 1B deficiency reduces insulin resistance and the diabetic phenotype in mice with polygenic insulin resistance. J Biol Chem 282, 23829-23840.
74. Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X, &, Zhai Q, (2007) SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 6, 307-319.
75. Ahmad F, Azevedo JL, Cortright R, Dohm GL, &, Goldstein BJ, (1997) Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J Clin Invest 100, 449-458.
76. Ahmad F, &, Goldstein BJ, (1995) Alterations in specific protein-tyrosine phosphatases accompany insulin resistance of streptozotocin diabetes. Am J Physiol 268, E932-940.
77. Kennedy BP, &, Ramachandran C, (2000) Protein tyrosine phosphatase-1B in diabetes. Biochem Pharmacol 60, 877-883.
78. Zabolotny JM, Kim YB, Welsh LA, Kershaw EE, Neel BG, &, Kahn BB, (2008) Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J Biol Chem 283, 14230-14241.
79. Agouni A, Mody N, Owen C, Czopek A, Zimmer D, Bentires-Alj M, Bence KK, &, Delibegovic M, (2011) Liver-specific deletion of protein tyrosine phosphatase (PTP) 1B improves obesity- and pharmacologically induced endoplasmic reticulum stress. Biochem J 438, 369-378.
80. Zabolotny JM, Haj FG, Kim YB, Kim HJ, Shulman GI, Kim JK, Neel BG, &, Kahn BB, (2004) Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J Biol Chem 279, 24844-24851.
81. Palmer ND, Bento JL, Mychaleckyj JC, Langefeld CD, Campbell JK, Norris JM, Haffner SM, Bergman RN, &, Bowden DW, (2004) Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes 53, 3013-3019.
82. Bento JL, Palmer ND, Mychaleckyj JC, Lange LA, Langefeld CD, Rich SS, Freedman BI, &, Bowden DW, (2004) Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes 53, 3007-3012.
83. Di Paola R, Frittitta L, Miscio G, Bozzali M, Baratta R, Centra M, Spampinato D, Santagati MG, Ercolino T, Cisternino C, et al. (2002) A variation in 3′ UTR of hPTP1B increases specific gene expression and associates with insulin resistance. Am J Hum Genet 70, 806-812.
84. Gum RJ, Gaede LL, Koterski SL, Heindel M, Clampit JE, Zinker BA, Trevillyan JM, Ulrich RG, Jirousek MR, &, Rondinone CM, (2003) Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Diabetes 52, 21-28.
85. Zinker BA, Rondinone CM, Trevillyan JM, Gum RJ, Clampit JE, Waring JF, Xie N, Wilcox D, Jacobson P, Frost L, et al. (2002) PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc Natl Acad Sci USA 99, 11357-11362.
86. Rondinone CM, Trevillyan JM, Clampit J, Gum RJ, Berg C, Kroeger P, Frost L, Zinker BA, Reilly R, Ulrich R, et al. (2002) Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis. Diabetes 51, 2405-2411.
87. Zhang S, &, Zhang ZY, (2007) PTP1B as a drug target: recent developments in PTP1B inhibitor discovery. Drug Discov Today 12, 373-381.
88. Chen C, Zhang Y, &, Huang C, (2010) Berberine inhibits PTP1B activity and mimics insulin action. Biochem Biophys Res Commun 397, 543-547.
89. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, et al. (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450, 712-716.
90. Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S, et al. (2011) Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14, 612-622.
91. Cool DE, Tonks NK, Charbonneau H, Walsh KA, Fischer EH, &, Krebs EG, (1989) cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatse family. Proc Natl Acad Sci USA 86, 5257-5261.
92. Galic S, Klingler-Hoffmann M, Fodero-Tavoletti MT, Puryer MA, Meng TC, Tonks NK, &, Tiganis T, (2003) Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP. Mol Cell Biol 23, 2096-2108.
93. Lam MH, Michell BJ, Fodero-Tavoletti MT, Kemp BE, Tonks NK, &, Tiganis T, (2001) Cellular stress regulates the nucleocytoplasmic distribution of the protein tyrosine phosphatase TCPTP. J Biol Chem 276, 37700-37707.
94. Shc are specific substrates of T-cell protein tyrosine phosphatase. Mol Cell Biol 18, 1622-1634.
95. Fukushima A, Loh K, Galic S, Fam B, Shields B, Wiede F, Tremblay ML, Watt MJ, Andrikopoulos S, &, Tiganis T, (2010) T-cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis. Diabetes 59, 1906-1914.
96. Galic S, Hauser C, Kahn BB, Haj FG, Neel BG, Tonks NK, &, Tiganis T, (2005) Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP. Mol Cell Biol 25, 819-829.
97. Klingler-Hoffmann M, Fodero-Tavoletti MT, Mishima K, Narita Y, Cavenee WK, Furnari FB, Huang HJ, &, Tiganis T, (2001) The protein tyrosine phosphatase TCPTP suppresses the tumorigenicity of glioblastoma cells expressing a mutant epidermal growth factor receptor. J Biol Chem 276, 46313-46318.
98. Tiganis T, Kemp BE, &, Tonks NK, (1999) The protein tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and phosphatidylinositol 3-kinase-dependent signalling. J Biol Chem 274, 27768-27775.
99. Mattila E, Pellinen T, Nevo J, Vuoriluoto K, Arjonen A, &, Ivaska J, (2005) Negative regulation of EGFR signalling through integrin-α1β1- mediated activation of protein tyrosine phosphatase TCPTP. Nat Cell Biol 7, 78-85.
100. Persson C, Savenhed C, Bourdeau A, Tremblay ML, Markova B, Bohmer FD, Haj FG, Neel BG, Elson A, Heldin CH, et al. (2004) Site-selective regulation of platelet-derived growth factor β receptor tyrosine phosphorylation by T-cell protein tyrosine phosphatase. Mol Cell Biol 24, 2190-2201.
101. Sangwan V, Paliouras GN, Abella JV, Dube N, Monast A, Tremblay ML, &, Park M, (2008) Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase. J Biol Chem 283, 34374-34383.
102. van Vliet C, Bukczynska PE, Puryer MA, Sadek CM, Shields BJ, Tremblay ML, &, Tiganis T, (2005) Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase. Nat Immunol 6, 253-260.
103. Loh K, Fukushima A, Zhang X, Galic S, Briggs D, Enriori PJ, Simonds S, Wiede F, Reichenbach A, Hauser C, et al. (2011) Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance. Cell Metab 14, 684-699.
104. Shields BJ, Hauser C, Bukczynska PE, Court NW, &, Tiganis T, (2008) DNA replication stalling attenuates tyrosine kinase signaling to suppress S phase progression. Cancer Cell 14, 166-179.
105. Wiede F, Shields BJ, Chew SH, Kyparissoudis K, van Vliet C, Galic S, Tremblay ML, Russell SM, Godfrey DI, &, Tiganis T, (2011) T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice. J Clin Invest 121, 4758-4774.
106. Simoncic PD, Lee-Loy A, Barber DL, Tremblay ML, &, McGlade CJ, (2002) The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3. Curr Biol 12, 446-453.
107. ten Hoeve J, Ibarra-Sanchez MJ, Fu Y, Zhu W, Tremblay M, David M, &, Shuai K, (2002) Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol Cell Biol 22, 5662-5668.
108. Aoki N, &, Matsuda T, (2002) A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. Mol Endocrinol 16, 58-69.
109. Yamamoto T, Sekine Y, Kashima K, Kubota A, Sato N, Aoki N, &, Matsuda T, (2002) The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation. Biochem Biophys Res Commun 297, 811-817.
110. You-Ten KE, Muise ES, Itie A, Michaliszyn E, Wagner J, Jothy S, Lapp WS, &, Tremblay ML, (1997) Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J Exp Med 186, 683-693.
111. Heinonen KM, Nestel FP, Newell EW, Charette G, Seemayer TA, Tremblay ML, &, Lapp WS, (2004) T cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease. Blood 103, 3457-3464.
112. Bourdeau A, Dube N, Heinonen KM, Theberge JF, Doody KM, &, Tremblay ML, (2007) TC-PTP-deficient bone marrow stromal cells fail to support normal B lymphopoiesis due to abnormal secretion of interferon-γ. Blood 109, 4220-4228.
113. Andersen JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, Jansen PG, Andersen HS, Tonks NK, &, Moller NP, (2001) Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol Cell Biol 21, 7117-7136.
114. Salmeen A, Andersen JN, Myers MP, Tonks NK, &, Barford D, (2000) Molecular basis for recognition and dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. Mol Cell 6, 1401-1412.
115. Iversen LF, Moller KB, Pedersen AK, Peters GH, Petersen AS, Andersen HS, Branner S, Mortensen SB, &, Moller NP, (2002) Structure determination of T cell protein tyrosine phosphatase. J Biol Chem 277, 19982-19990.
116. Myers MP, Andersen JN, Cheng A, Tremblay ML, Horvath CM, Parisien JP, Salmeen A, Barford D, &, Tonks NK, (2001) TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J Biol Chem 276, 47771-47774.
117. Egan C, Pang A, Durda D, Cheng HC, Wang JH, &, Fujita DJ, (1999) Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530. Oncogene 18, 1227-1237.
118. Dadke S, &, Chernoff J, (2003) Protein-tyrosine phosphatase 1B mediates the effects of insulin on the actin cytoskeleton in immortalized fibroblasts. J Biol Chem 278, 40607-40611.
119. Garton AJ, Burnham MR, Bouton AH, &, Tonks NK, (1997) Association of PTP-PEST with the SH3 domain of p130cas; a novel mechanism of protein tyrosine phosphatase substrate recognition. Oncogene 15, 877-885.
120. Liu F, Hill DE, &, Chernoff J, (1996) Direct binding of the proline-rich region of protein tyrosine phosphatase 1B to the Src homology 3 domain of p130(Cas). J Biol Chem 271, 31290-31295.
121. Dadke S, &, Chernoff J, (2002) Interaction of protein tyrosine phosphatase (PTP) 1B with its substrates is influenced by two distinct binding domains. Biochem J 364, 377-383.
122. Liu F, Sells MA, &, Chernoff J, (1998) Transformation suppression by protein tyrosine phosphatase 1B requires a functional SH3 ligand. Mol Cell Biol 18, 250-259.
123. Kant S, Swat W, Zhang S, Zhang ZY, Neel BG, Flavell RA, &, Davis RJ, (2011) TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway. Genes Dev 25, 2069-2078.
124. Scharl M, McCole DF, Weber A, Vavricka SR, Frei P, Kellermeier S, Pesch T, Fried M, &, Rogler G, (2011) Protein tyrosine phosphatase N2 regulates TNFα-induced signalling and cytokine secretion in human intestinal epithelial cells. Gut 60, 189-197.
125. Bettaieb A, Liu S, Xi Y, Nagata N, Matsuo K, Matsuo I, Chahed S, Bakke J, Keilhack H, Tiganis T, et al. (2011) Differential regulation of endoplasmic reticulum stress by protein tyrosine phosphatase 1B and T cell protein tyrosine phosphatase. J Biol Chem 286, 9225-9235.
126. Meng TC, Buckley DA, Galic S, Tiganis T, &, Tonks NK, (2004) Regulation of insulin signaling through reversible oxidation of the protein-tyrosine phosphatases TC45 and PTP1B. J Biol Chem 279, 37716-37725.
127. Lu X, Chen J, Sasmono RT, Hsi ED, Sarosiek KA, Tiganis T, &, Lossos IS, (2007) T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6. Mol Cell Biol 27, 2166-2179.
128. Lu X, Malumbres R, Shields B, Jiang X, Sarosiek KA, Natkunam Y, Tiganis T, &, Lossos IS, (2008) PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling. Blood, 112, 4098-4108.
129. Flint AJ, Tiganis T, Barford D, &, Tonks NK, (1997) Development of 'substrate-trapping' mutants to identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci USA 94, 1680-1685.
130. Tiganis T, (2011) Reactive oxygen species and insulin resistance: the good, the bad and the ugly. Trends Pharmacol Sci 32, 82-89.
131. Delibegovic M, Bence KK, Mody N, Hong EG, Ko HJ, Kim JK, Kahn BB, &, Neel BG, (2007) Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B. Mol Cell Biol 27, 7727-7734.
132. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, Bailey R, Nejentsev S, Field SF, Payne F, et al. (2007) Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39, 857-864.
133. Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, Howson JM, Stevens H, McManus R, Wijmenga C, et al. (2008) Shared and distinct genetic variants in type 1 diabetes and celiac disease. New Engl J Med 359, 2767-2777.
134. Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678.